These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23878608)

  • 21. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation.
    Lee WY; Chiu LC; Yeung JH
    Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
    J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
    Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.
    Yang H; Zhang J; Li J; Zhao F; Shen Y; Xing X
    Exp Ther Med; 2018 Nov; 16(5):4296-4302. PubMed ID: 30344703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.
    Guo Y; Li Y; Xiang B; Huang XO; Ma HB; Wang FF; Gong YP
    Biochem J; 2017 Dec; 474(24):4153-4170. PubMed ID: 29046392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
    Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
    Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hydrolysed products of iridoid glycosides can enhance imatinib mesylate-induced apoptosis in human myeloid leukaemia cells.
    Kim MB; Kim C; Chung WS; Cho JH; Nam D; Kim SH; Ahn KS
    Phytother Res; 2015 Mar; 29(3):434-43. PubMed ID: 25583173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro.
    Liu JJ; Lin DJ; Liu PQ; Huang M; Li XD; Huang RW
    J Biomed Sci; 2006 Nov; 13(6):813-23. PubMed ID: 16955348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth.
    Wang X; Zeng J; Shi M; Zhao S; Bai W; Cao W; Tu Z; Huang Z; Feng W
    DNA Cell Biol; 2011 Feb; 30(2):71-8. PubMed ID: 21091189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone.
    Kim HK; Woo ER; Lee HW; Park HR; Kim HN; Jung YK; Choi JY; Chae SW; Kim HR; Chae HJ
    Immunopharmacol Immunotoxicol; 2008; 30(2):347-64. PubMed ID: 18569089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway.
    Zhang W; Liu M; Ji Y; Yu D; Ma C; Zhao J; Qu P
    Arch Biochem Biophys; 2023 Jul; 743():109655. PubMed ID: 37285895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings.
    Zhu Jf; Li Zj; Zhang Gs; Meng K; Kuang Wy; Li J; Zhou Xf; Li Rj; Peng Hl; Dai Cw; Shen JK; Gong Fj; Xu Yx; Liu Sf
    PLoS One; 2011; 6(8):e23720. PubMed ID: 21887305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proapoptotic and TRAIL-sensitizing constituents isolated from Salvia militiorrhiza (Danshen).
    Chang CC; Lai JS; Tsai CS; Ma SW; Lin JY; Huang LR; Lu CH; Liao EC; Ho TF
    J Biosci Bioeng; 2013 Oct; 116(4):516-23. PubMed ID: 23660075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer.
    Zhang Y; Guo S; Fang J; Peng B; Zhang Y; Cao T
    Exp Ther Med; 2018 Oct; 16(4):2931-2937. PubMed ID: 30214513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydrocostus Lactone Suppresses Proliferation of Human Chronic Myeloid Leukemia Cells Through Bcr/Abl-JAK/STAT Signaling Pathways.
    Cai H; Qin X; Yang C
    J Cell Biochem; 2017 Oct; 118(10):3381-3390. PubMed ID: 28300289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
    Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
    PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.